| European Case Law Identifier: | ECLI:EP:BA:2015:T224812.20151029 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 29 October 2015 | ||||||||
| Case number: | T 2248/12 | ||||||||
| Application number: | 02766436.6 | ||||||||
| IPC class: | C07K 14/52 A61K 38/19 C07H 21/04 C12N 15/63 C12N 1/21 C12N 1/11 C12N 5/16 C12N 15/12 C07K 14/705 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Apo-2 ligand variants and uses thereof | ||||||||
| Applicant name: | Genentech, Inc. | ||||||||
| Opponent name: | - | ||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Unity of invention - (yes) Appeal decision - remittal to the examining divsion (yes) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t122248eu1.html
Date retrieved: 17 May 2021